The Impact of the World Workshops on Oral Health and Disease in HIV/AIDS

Prof. John Greenspan, BSc, BDS, Ph.D, FRCPath, ScD, FDRCS (ENG), FKC is a Professor and Associate Dean for Global Oral Health, and a Distinguished Professor of Pathology in the School of Dentistry and Medicine, University of California San Francisco (UCSF). His research interest centres on the epidemiology, etiopathogenesis and management of oral soft tissue diseases, notably those associated with HIV infection and other causes of immunosuppression, as well as aphthous ulcers, Sjögren's syndrome, and oral cancer/pre-cancer. He has worked on the epidemiologic and genetic studies on Sjögren's Syndrome, as well as continuing the expansion of translational research on HIV in across basic, clinical, and behavioural sciences. He has co-authored a study on the natural history and pathogenesis of HIV-infection in a large cohort of women at risk for AIDS in the San Francisco Bay Area. He is a Founding Director of the UCSF Oral AIDS Center (OAC), the Founding Chair of Global Oral Health Interest Group from the Consortium of Universities for Global Health, and the Founding President of Global Oral Health Inequalities Network of the International Association for Dental Research. He was co-PI of the UCSF site of the international oral AIDS program that was part of the NIAID-funded AIDS Clinical Trails Network (ACTG). He co-founded the on-going series of World Workshops on Oral AIDS in 1987 and led the first three Workshops and served on the leadership group of the subsequent four Workshops. He provides advice and support to many undergraduate and DDS/PhD students, as well as mentoring a number of junior and senior faculty members of the UCSF/Gladstone Institute of Immunology and Virology Center for AIDS Research Mentoring program. He has received numerous grants and honors, including John Greene Society Faculty Research Award, American Association of Dental Research (AADR) Distinguished Scientist Award, King’s College London Dental Institute Alumnus of the Year Award, American Dental Association Gold Medal for Excellence in Dental Research, and UCSF Academic Senate Faculty Research Lecture Award –Translational Science. He is listed in Who's Who in America since 1997.

Global Overview of HIV

Chair of Plenary Session 3 and Session 6

Prof. Stephen J. Challacombe, BDS, Ph.D, FDSRCSEd, FRCPAth, FmedSci, FDSRCS. is a renowned researcher and clinical specialist in oral medicine. He is the Martin Rushton Professor of Oral Medicine in University of London & King’s College London. He is past President of the International Association for Dental Research (IADR) and current president of the Hunterian Society. He has had a long professional interest in the oral manifestations of HIV and on mucosal immunity in HIV which has led to over 25 research papers. He was part of the consensus meeting on the classification of the oral lesions in HIV in 1991 and 1993. Since 1996, He was the Co-chairman of International workshops on the oral manifestations of HIV infection in the UK, South Africa, Thailand, China, and India. From 2000-2017 he was Chairman of the International steering committee on Oral Health & Disease in HIV infection. He has been an author or co-author of over 240 peer-reviewed research papers and 160 other publications on Mucosal immunity; Immunological, dermatological and microbiological aspects of oral diseases; Oral medicine; Candida infections; Immunological aspects of Dental Caries, Oral manifestations of HIV infection, Oral Tolerance. Editor or co-editor of 9 books on Food Allergy, Food Allergy & Intolerance, Practical and Theoretical aspects of ELISA, Oral Aids Research, and Immunology of oral diseases. Early in his academic career he was an Assistant Professor & Senior Research Fellow in the Department of Immunology, Mayo Clinic, USA (1978-1979), and his career includes serving as Dean for International Affairs, KCL health Schools (2007-2012). He served as President of British Society for Oral Medicine (1995-1997), President of European Association of Oral Medicine (2008-2010), and from 2007- 2013, he was Chairman of the Expert Specialist Advisory Group for OHARA (oral section of Aids clinical trials group). In addition to all his tremendous activities related to oral health and diseases in HIV/AIDS, he also has extensive experience in administration which includes running the University departments, organising conferences, managing grants, budgets and research, teaching and clinical activities. He has received a number of awards for his research. Recently, he received a Samuel Charles Miller award from the American Academy of Oral Medicine.

The Changing Pattern of the Epidemiology of the Oral Manifestations of HIV Worldwide

Chair of Plenary Session 4

Prof. Dr. Anwar R Tappuni, BDS, LDSRCS, Ph.D, MRACDS(OM) is Reader/Honorary Consultant/Academic Lead for Oral Medicine at the Queen Mary University of London, and the Director of Doctorate in Clinical Dentistry in Oral Medicine. She was the Honorary Professor in School of Dentistry, Saveetha University, India (2017). She has several high profile international and national roles including President of the Oral Medicine and Pathology Group from International Association for Dental Research, and President of the Oral Medicine and Pathology Group from British Society for Oral and Dental Research. She is also Chair of the BMA/BDA Refugee Doctors and Dentists Liaison Group. She is on the Medical Council and a Trustee for the British Sjögren’s Syndrome Association. She leads a successful multidisciplinary clinic with rheumatology consultants, providing specialized clinical service for Sjögren’s syndrome patients. She led on writing the National Treatment Guidelines for Treatment of Sjögren’s in Adults, which was ratified by the National Institute for Clinical Excellence, the British Society for Rheumatology, and The British Health Professionals in Rheumatology. She is the invited Editor for a Text Book on Sjögren’s Syndrome commissioned by Oxford University Press. She co-chaired the International Steering Committee and the meeting of the 7th World Workshop for Oral Health and Disease in AIDS (2014) in Hyderabad, India. She also co-authored the Hyderabad declaration which called for equal opportunities for HIV patients to access resources. She was Member of the Editorial Board of Journal of Dental Research, and Guest Editor for a Supplement of the Journal of Oral Diseases. She has developed and published a clinical tool for assessing the severity of oral ulcerative disease, which has been adopted for use in several clinical units and employed in clinical trials. She has been involved in developing severity scores for oral mucosal diseases and formulated an Ulcer Severity Score (USS) which has been validated and adopted by several Oral Medicine departments and proved to be valuable as an outcome measure in clinical trials. On her current research, she is investigating Sjögren's Syndrome from the safety and efficacy of the treatment, molecular imaging methods, risk factors, and other tests. She has been awarded the BDA Roll of Distinction for outstanding service to UK dentistry.

Oral Health and HIV: What Dental Students Need to Know

Prof. Paul Coulthard BDS, MFGDP(UK), MDS, FDSRCS, FDS(OS)RCS, PhD is Dean for Dentistry and Director at ‘Barts and The London School of Medicine and Dentistry’, Queen Mary University of London, and Professor of Oral and Maxillofacial Surgery. He is Consultant in Oral Surgery at ‘Barts Health NHS Trust’ that includes St Bartholomew’s Hospital and The Royal London Hospital. He was previously Head of the Manchester Medical School and Research Institutes of Cancer Sciences, Cardiovascular Sciences, Developmental Biology & Medicine, Diabetes, Endocrinology & Gastroenterology. Prior to this he was Manchester Dental School Dean for five years. Alongside surgical training, Professor Coulthard undertook research training leading to the award of an MDS in Oral and Maxillofacial Surgery and a PhD in Neuroscience. He has published over 180 scientific papers. Professor Coulthard has chaired several recent committees for ‘NHS England’ that have published reports changing the delivery of clinical care in England. He is President-Elect of the ‘British Association of Oral Surgeons’ becoming President in September 2019. Professor Coulthard is actively involved in undergraduate and postgraduate teaching and learning. He is passionate about Evidence-Based Practice and teaching this concept to students. He is principal author of a textbook Oral and Maxillofacial Surgery, Radiology, Pathology and Oral Medicine (Master Dentistry Volume 1) and has also authored chapters for six other textbooks.

Chair of Plenary Session 5

Prof. Paula Moynihan is Director of Food and Health in the Faculty of Health and Medical Sciences. She is an internationally renowned researcher in the field of nutrition and oral health (> 130 publications). Her research focuses on the interrelationship between nutrition and oral health across the life-course, including the impact of diet and nutrition on dental caries, sugars and health, and the impact of compromised oral health on nutritional wellbeing. She also researches novel approaches to dietary intervention using co-development methods, and mixed methods evaluation. Recent projects include evaluation of Public Health England’s Change4Life Sugar Smart Campaign, and evidence synthesis pertaining to risk factors for Early Childhood Caries tooth decay in children. Paula Moynihan is Professor of Nutrition and Oral Health and Director of the Centre for Oral Health Research at Newcastle University UK. She also is Director of the WHO Collaborating Centre for Nutrition and Oral Health at Newcastle University. Her research interests include the interrelationship between nutrition and oral health throughout the life course, and dietary intervention in older adults. Being Expert advisor, on carbohydrates and dental health, to the WHO Nutrition Guideline Advisory Group, she led the WHO commissioned systematic review of evidence relating to amount of sugars and dental caries that has informed WHO guidelines on dietary sugars. She is also a member of the European Food Safety Authority Working Group on Added Sugars. Professor Moynihan is the Vice President of IADR and will take up this position of President Elect in July this year. She is currently President of the Geriatric Oral Research Group and a Past President of the Nutrition Research Group of IADR. In 2004 she was awarded the UK Nutrition Society’s Silver Medal for ‘Excellence in Research by a Young Scientist’. In 2010 she was awarded an IADR Distinguished Scientist Award for ‘Geriatric Oral Research’. Professor Moynihan has over 115 publications in peer reviewed journals, several book chapters and is on the editorial board for several scientific journals, including the Journal of Dental Research. She has presented her research at national and international conferences across the globe. Her current research includes an evaluation of Public Health England’s Sugar Smart Health Marketing Campaign which aims to reduce sugars intake by children.

Recent Research Advances in Oral Health and Disease in HIV/AIDS

Melissa Riddle, Ph.D earned a doctorate in clinical psychology from the University of Arizona in 1998. Her doctoral research combined family therapy and behavioral medicine, asking questions related to how patients and their families manage chronic or serious illness. In 1998, Melissa started a 2 ½ year postdoctoral fellowship at the University of Pennsylvania. During this fellowship, her research and clinical care focused on the psychosocial effects of genetic testing for breast and ovarian cancer risk for women and their families. In 2001, Melissa joined the National Institute on Drug Abuse (NIDA), overseeing grants programs on behavioral treatments for drug abuse and HIV risk behavior. She joined the National Institute of Dental and Craniofacial Research (NIDCR) in 2007, where she has served as chief of the Behavioral and Social Sciences Research Branch (BSSRB) ever since.

The Economic and Social Impact of HIV in Indonesia and Neighbouring Countries

Dr. Pandu Riono is a Senior Staff at University of Indonesia, Faculty of Public Health. He specializes in mathematical modeling of Infectious Diseases, including HIV/AIDS and Sexual Risk Network for HIV and STI, and also other infectious diseases. He was receiving some fellowships to study and attend the International Conference on Public Health issues. He was the recipient of Fogarty Fellowship to finishing his PhD in UCLA, 2001 with dissertation title is “Sexual Network among Men and STD/HIV Epidemic in Indonesia”. He was involved in the regional activities related with Risk Behavioral Analysis Workshop. He was Chair of Infectious Diseases Division Indonesian Medical Association Periode: 2003 - 2006 & 2006 – 2009. He was a Consultant for Asia-Pacific HIV-AIDS Data Hub, UNICEF Bangkok in 2007-2008. He also provides Technical consultants for HIV and Behavior Surveillance for MOH, including BSS among General Population in Papua. He is also the main editor for National HIV-AIDS related Risk Behavior Survey Reports since 2002, 2005, 2007, and until now. Since 2010, He was also appointed as Technical Consultant National TB Program, Developing National TB Estimation Methods. He is also a member of TB Operational Research Group – MOH and a member of AIDS Commission of Indonesian Medical Association. He has been appointed as International Consultant for WHO at Geneva.

HIV Testing in the Dental Setting: a Global Perspective of Feasibility and Acceptability

Anthony Santella, DrPH, MPH, MCHES is an Associate Professor of Public Health and LGBTQ+ Studies at Hofstra University in Long Island, New York. Long Island has the highest number of AIDS cases of any suburban area in the country and more cases than 26 states.

Dr. Santella also serves as Chair of the Long Island Ryan White HIV Planning Council, Governing Councilor of the HIV/AIDS Section of the American Public Health Association (APHA), Chair of the Committee on Health Equity of APHA, Associate Editor for Frontiers in Public Health, and Academic Editor for PLOS One. He also serves on the Board of Directors of The HIV League, a nonprofit organization which provides scholarships to people living with HIV pursuing a university degree.

Dr. Santella is a public health scientist and health services researcher specializing in HIV and STI prevention and sexual health. His research agenda focuses on the integration of primary and secondary prevention in clinical settings. Specifically, his work explores the role of dental professionals (dentists and dental hygienists) in conducting rapid HIV testing in the dental setting. Using qualitative, quantitative, and mixed-methods research he has led, co-led, and advised on projects conducted in the United States, United Kingdom, China, India, Vietnam, and Australia alongside in-country dental clinical and public health scholars. This research has been published in journals such as the Australian Dental Journal, British Dental Journal, Journal of Dental Hygiene, International Journal of Dental Hygiene, and Oral Health and Preventive Dentistry.

He has also received grants from the foundation, university, and government sectors and has presented his work at local, national and international conferences such as the American Public Health Association Annual Meeting, International AIDS Conference, and the International Association of Dental Research Annual Meeting.

Dr. Santella earned a Bachelor of Science in Biomedical Sciences from the University of Connecticut (Storrs, Connecticut, US), a Master of Public Health in Health Policy and Management from Emory University (Atlanta, Georgia, US), a Doctor of Public Health in Health Systems Management from Tulane University (New Orleans, Louisiana, US), and an Advanced Certificate in Health Professions Pedagogy and Leadership from Hofstra University (Long Island, New York, US). He is also a Master Certified Health Education Specialist by the National Commission of Health Education Credentialing.

Sexual and Reproductive Health and Human Rights of Women Living with HIV

Anandi Yuvaraj is an AIDS activist and HIV and SRHR consultant based in India. Anandi worked as a consultant with UNAIDS, India office supporting a multi-country project on Gender based Violence and HIV being implemented by research partners and CBOs and South to South Initiative. She is a member of International Community of Women Living with HIV (ICW Global). Anandi spearheaded the Asia Pacific Regional Chapter of ICW as Regional Coordinator from 2008-2012. During this period, she led community based research using PLHIV Stigma Index tool to measure the level of stigma experienced by PLHIV in Tamil Nadu and Northeast states with UNAIDS support. She was awarded a research project by ICMR to assess Sexual and Reproductive Rights of Women with HIV using quantitative methodology. Prior to joining ICW, Anandi worked as Program Manager for HIV and Sexual Reproductive Health at PATH’s India office, where she managed an advocacy project of the Global Campaign for Microbicides (GCM) in India. Anandi has served on many high level committees at the global level to scale up HIV programmes in developing countries. She also served as a steering committee member of UNAIDS second evaluation process in 2010. She was also employed by the International HIV/AIDS Alliance in India as Senior Programme Officer for over five years. During this tenure she got involved with the Global Fund fight for AIDS, TB and Malaria (GFATM) as the Board representative of the Communities Delegation (2004-06).

HIV Interaction in Mucosal Epithelium

Sharof M. Tugizov, DVM, Ph.D, DSc has research focus is investigation of the interactions of human viruses, including human cytomegalovirus (HCMV), Epstein–Barr virus (EBV), Herpes simplex virus (HSV), human immunodeficiency virus (HIV), and human papillomavirus (HPV), with monostratified and multistratified oral epithelia. He has made significant contributions to current knowledge about entry, transcytosis, intracellular transport, egress, and cell-to-cell transmission of these viruses in oral epithelial cells by establishing and using polarized epithelial cells, as well as ex vivo oral mucosal tissue explants.

Chair of Plenary Session 1

Prof. Deborah Greenspan, BDS, DSc. is one of the world’s leading investigators and clinicians in oral infectious diseases, especially in relation to HIV/AIDS. She has worked with colleagues throughout the world to improve oral and general health of this group of patients. Her international work includes training a generation of clinicians, many from resource poor countries, both in clinical care and in the development of research programs. She has made crucial discoveries concerning oral health, including delineating new lesions in association with HIV infection, for example her co-discovery of oral hairy leukoplakia, and new ways of treating the mouth problems in HIV positive people. She has charted the changes in the AIDS epidemic since its beginning in San Francisco. Her co-discovery of hairy leukoplakia opened up new aspects, not only of AIDS research worldwide but also in the field of Epstein-Barr virus research. Her group pioneered effective oral care for the millions of people worldwide with HIV infection, and set an example for delivery of dental care for that group. She led the UCSF School of Dentistry’s effort to establish new protocols to protect patients and health care providers against transmission of blood-borne infections. This example set the standard. She has made major contributions to improving oral health for people with oral cancer who have been treated with radiation therapy. She is an international leader in oral science and has spoken extensively on oral cancer, oral candidiasis, AIDS, the oral manifestations of HIV infection and infection control and has given many radio, television and print media interviews. She is Professor-Emerita of Oral Medicine and the past Chair of the Department of Orofacial Sciences at the University of California San Francisco, Past President of the International Association for Dental Research, former Chair of the San Francisco Division of the University of California Academic Senate 2005 to 2007. She is a Fellow of the American Association for the Advancement of Science and a member of the National Academy of Medicine. In 2000, she received the Silver Medal of the Ville de Paris, in 2004, Norton Ross Award from the American Dental Association, while in 2009 she received the Frederick Birnberg Award for Excellence in Dental Research from Columbia University College of Dental Medicine and in 2011 she received the Distinguished Scientist Award in Oral Medicine and Pathology from the International Association for Dental Research. The ScD (hc) was conferred on her by Georgetown University, the FDSRCS (Hon) by the Royal College of Surgeons of Edinburgh, in 2007 the DSc (hc) by Kings College, University of London, UK and in 2008, the DDS (hc) by the University of Sheffield UK. She received the Positive Health Practice Award of the 360 HIV/AIDS Clinic at UCSF in 2008 and in 2009 the Frederick Birnberg Award from Columbia University College of Dental Medicine, New York. She has been an Ambassador in Research America’s Paul G Roger’s Society for Global Health Research. She is a Fellow of the International College of Dentists and of the American College of Dentists.

Co-Chair of Plenary Session 1

Dr. Irna Sufiawati, drg., Sp.PM (K)., Ph.D is currently Associate Professor and Head of Oral Medicine Department at Faculty Dentistry University of Padjadjaran. She has been interested in the field of HIV/AIDS since she worked in Public Health Centre Wamena, Papua, East Indonesia, and decided to continues her education and research in infectious diseases. She had completed a sandwich Ph.D program in 2011 at the University California of San Francisco (UCSF), San Francisco, United States of America, majoring in Virology. Ever since, she dedicated herself in the area of HIV infections, which is a serious impediment for oral health in Indonesia. She is member of AIDS prevention and control commission in West Java-Indonesia and served as an oral and dental health coordinator and consultant in HIV/AIDS Clinic in the central reference Dr. Hasan Sadikin Hospital Bandung West Java that has become one of the provinces with the highest number of people living with AIDS in Indonesia. She has had invited as the main speaker in local and regional events, especially in the topics related to HIV and sexually transmitted diseases. She is a chairman of Indonesian Oral Medicine Association Region II and a curriculum coordinator of Indonesian Collegium of Oral Medicine. She has been awarded a number of honours since 12 years ago, such as the Best Research Award in the FDI World Dental Federation–Indonesian Dental Association Joint Meeting 2016, in Forsila III 2017, and in the International Conference on Biophysical Technology in Dentistry in conjunction with International Scientific Meeting in Dentistry 2018. Her research interests include the epidemiology, etiopathogenesis and management of oral diseases associated with HIV/AIDS, oral precancer and oral mucositis associated with cancer therapy, oral manifestation of autoimmune diseases especially lupus erythematosus, and salivary diagnostic. Alongside her teaching and research background, she has ample experience of effectively organising scientific conferences and workshops in the level of local and national in Indonesia.

Chair of Plenary Session 2

Dr. Christopher Hughes Fox, MSc, MDSC is an Chief Executive Officer of the International Association for Dental Research and the American Association for Dental Research. He has been the PI of The 6th and 7th International Workshops on Oral Health and Diseases in AIDS held in China (2009) and India (2014), organised by the National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR). He is also the PI of an FDA conference grant on oral health effects of tobacco products, and currently PI of an NIH/NIDCR Bloc Travel Grant. He has extensive experience in organising both domestic and international scientific conferences. His early career focused on the epidemiology of the periodontal disease. However, having worked for a private multinational oral health consumer company, his research was broadened from clinical disease to translating research findings into practice behaviours. He is passionate about public policy being adequately informed by the latest available evidence and to identify research gaps where they exist, and to advocate for research funding to address those gaps – an area which certainly applies to oral health and disease in HIV/AIDS. Working with the IADR Board of Directors and other key stakeholders, he has brought attention to the need for research to inform the global oral health policy agenda and to address global oral health inequalities. He received many awards, including the Harvard School of Dental Medicine Distinguished Alumnus Award (2007). In the past three years, He was awarded a Fellow of American Association for Dental Research (2016) and American Academy for the Advancement of Science (2017). This year He received the Alan J. Davis/SCADA Achievement Award.

a

Co-Chair of Plenary Session 2

Prof. Dr. dr. Ketut Tuti Parwati Merati, SpPD-KPTI, FINASIM is professor of Medical Science, Internal medicine department. She is Head of Infection and Tropic disease Division RSUP Sanglah Denpasar, Bali and Lecturer Faculty of Medicine, Udayana University, Denpasar, Bali. In 1997, she is Consultant of Infection and Tropic disease. She is Founder and Chief of Citra Usadha Indonesia Foundation (YCUI), Chief of Forum Lembaga Peduli AIDS (FLPA) and Chief of PETRI (Perhimpunan Peneliti Penyakit Tropis dan Infeksi), Bali Branch.

Co-Chair of Plenary Session 3

Dr. Agnes Rengga Indrati, dr., M.Kes., Sp.PK(K) is Doctor in Clinical Pathology Departemen Hasan Sadikin Hospital. She is a Head of Clinical Pathology Specialist Program Faculty of Medicine University Padjajaran and a head of The Laboratories of “Klinik Teratai” (HIV/AIDS center Hasan Sadikin Hospital). Her research focuses on HIV, including Integration Management of Patient of HIV and AIDS Care and Treatment, HIV Receptors in people with HIV / AIDS Injecting Drug users, Methods of Diagnosing Interferon Gamma in the TB-SPOT Method in Patients with TB-HIV, Impact of Early HIV testing and therapy strategy interventions on gay and female sex worker populations in Indonesia, Cytokine Profile in Latent TB Patients with HIV, Expression of Human Immunodeficiency Virus Co-receptors CCR5 and CXCR4 on Lymphocyte T Subset and Monocyte.

Co-Chair of Plenary Session 4

Rudi Wisaksana, dr., Sp.PD-KPTI., PhD. He is the Head of Tropical and Infectious Diseases Division, Department of Internal Medicine, Faculty of Medicine Padjajaran University. He had completed the Ph.D Program at Radboud University Nijmegen, Netherlands. He leads some organization, including Head of HIV/AIDS Team, Hasan Sadikin Hospital Bandung, Indonesia; Head of Research and Development Working Group, West Java Provincial AIDS Commission, Bandung, Indonesia; Head of Tropical and Infectious Diseases Division, Department of Internal Medicine, Hasan Sadikin Hospital, Faculty of Medicine. He is a member of HIV Expert Panel on Operational Research, Ministry of Health, Indonesia and member of TB-HIV Working Group, Medical Faculty, Padjadjaran University Bandung, Indonesia. He received got some research grants, including joint rapid assessment on the strategic use of ART to reduce HIV related mortality and to prevent HIV transmission in Indonesia from National AIDS Commission, Ministry of Health, USAID. His major research interest is on the challenges in delivering HIV-care in Indonesia, and the barriers, challenges & good practices in delivering antiretroviral treatment.

Co-Chair of Plenary session 6

dr. Anak Agung Ayu Yuli Gayatri, SpPD-KPTI, FINASIM completed an internal medicine specialist in 2006 from Udayana University, Bali. In 2013-2017 became a specialist consultant doctor. She was Worked at Sanglah Hospital, Bali from 2009 until now as Staff of the Division of Tropical Diseases and Infectious Diseases Section. She was a member of the Indonesian Association of Tropical Infectious Diseases Researchers (PETRI) from 2010 until now. The final research was titled Hypovitaminosis D as a risk factor for TB-HIV co-infection.

Co-Chair of Plenary session 5

Ronald Jonathan, dr. is National Facilitator/Trainer for CST and IMAI in HIV/AIDS, TB/HIV. PITC and Palliative care (working together with MOH), Private practice as a GP handling mainly HIV/AIDS cases and working at Rumah Cemara which is a community based organisation of PLWHA and IDU. In August 2008 until now as a guest lecture at Faculty of Medicine Maranatha Christian University, Free lance consultant in HIV/AIDS doing clinical mentoring for doctors and nurses ( 3-5 days/ province) in several provinces in Indonesia, National trainer for CST/IMAI --- HIV/AIDS with MOH, Training Treatment educator for Positive support group in Medan( with Medan Plus) and Bandung ( with Rumah Cemara/ Bandung Plus Support)/( 2-3 days per training), Translating HIV/AIDS modules (with FHI/ASA), Doing clinical work as a GP and VCT counsellor, treating mainly HIV/AIDS.

HIV and stigma (Chair)

Anandi Yuvaraj is an AIDS activist and HIV and SRHR consultant based in India. Anandi worked as a consultant with UNAIDS, India office supporting a multi-country project on Gender based Violence and HIV being implemented by research partners and CBOs and South to South Initiative. She is a member of International Community of Women Living with HIV (ICW Global). Anandi spearheaded the Asia Pacific Regional Chapter of ICW as Regional Coordinator from 2008-2012. During this period, she led community based research using PLHIV Stigma Index tool to measure the level of stigma experienced by PLHIV in Tamil Nadu and Northeast states with UNAIDS support. She was awarded a research project by ICMR to assess Sexual and Reproductive Rights of Women with HIV using quantitative methodology. Prior to joining ICW, Anandi worked as Program Manager for HIV and Sexual Reproductive Health at PATH’s India office, where she managed an advocacy project of the Global Campaign for Microbicides (GCM) in India. Anandi has served on many high level committees at the global level to scale up HIV programmes in developing countries. She also served as a steering committee member of UNAIDS second evaluation process in 2010. She was also employed by the International HIV/AIDS Alliance in India as Senior Programme Officer for over five years. During this tenure she got involved with the Global Fund fight for AIDS, TB and Malaria (GFATM) as the Board representative of the Communities Delegation (2004-06).

HIV and Stigma (Co-Chair)

Chair of Plenary Session 6

Janine Doughty BDS, MDPH,DDPH RCSEng, PG Cert ClinRes is an National Institute for Healthcare Research Doctoral Research Fellow and previous Academic Speciality Registrar in Special Care Dentistry; Janine is currently out-of-programme undertaking a PhD to implement HIV testing in dental settings in London, England. Janine has a keen interest in public health and research, she has a Masters in Dental Public Health and a Post Graduate Certificate in Clinical Research, both awarded with distinction. Janine has worked collaboratively with Public Health England on the publication of the People Living with HIV Stigma Index 2015: Experiences of Stigma in the Dental Setting and is currently collaborating on the Positive Voices study to present attendance patterns, medical co-morbidities and stigma experienced by people living with HIV who have attended the dental setting. Janine has several leadership roles including: Associate Editor Dental Public Health in Action section of Community Dental Health Journal, Crisis at Christmas Homeless Dental Service Deputy Organiser, Pathway Homeless and Inclusion Oral Health Fellow, and she is also an Honorary Dental Advisor to the Chief Dental Officer, England. Janine has led the recent launch of the first national survey to map homeless and inclusive oral health services across England in order to identify examples of good practice and was the co-chair of the Homeless and Inclusion Oral Health symposium at the International Association of Dental Research conference, 2018. Janine has published and presented internationally on topics of medicine in dentistry including: HIV, pulmonary diseases, rare metabolic disorders, gastric pacemakers, thalassemia and fibrodysplasia ossificans progressiva. In recent years she has been awarded the British Association for Oral Surgery Senior House Officer open paper prize, Society for the Advancement of Anaesthesia in Dentistry essay prize, British Association for the Study of Community Dentistry Oral Health Promotion prize, she was a nominated finalist for the Bart’s Health Hero award and in 2018 was awarded the British Dental Association award for services to the association.

HIV and Stigma (Co-Chair)

Dr. Amitha Ranauta BDS, LLM is a Dentist from Queen Mary & Westfield & Barts And The London School of Medicine and Dentistry in 1996. Whilst working in General Dental Practice Amitha gained her LLM in Legal Aspects of Medical Practice from Cardiff University. Currently Amitha is working as a clinical lecturer at Queen Mary & Westfield & Barts and The London School of Medicine and Dentistry. She is involved in teaching hygiene & therapy students and undergraduate dental students. She is doing a PhD thesis exploring the topic of development professionalism in udenrgraduate dental students.

Interplay Between Oral Immunity in HIV and the Microbiome (Chair)

Prof. Paul Fidel, Jr. graduated from Allegheny College in Pennsylvania with a B.S. degree in Biology in 1984. He then attended the University of Oklahoma where he continued his studies, and received a M.S. in 1987 and Ph.D. in 1988 in the field of microbiology. He joined the Wayne State University School of Medicine in Detroit, Michigan as a postdoctoral fellow in the department of Immunology and Microbiology and was eventually appointed Assistant Professor of Medicine in the Department of Medicine, Division of Infectious Disease in 1990. In 1995, Dr. Fidel joined Louisiana State University Health Sciences Center in New Orleans as Associate Professor of Microbiology, Immunology, and Parasitology. He was granted tenure in 1997 and promoted to Professor in 1999. In 2001 Dr. Paul Fidel was named holder of the Carl Baldridge Chair in Oral and Craniofacial Biology and appointed the director of the Center of Excellence in Oral and Craniofacial Biology. Dr. Fidel has mentored numerous Ph.D students, medical/dental students, and junior faculty. He has authored over 160 publications and has served as Principal Investigator for over 20 research grants totaling over $30 million, 15 of which were from the National Institutes of Health. Dr. Paul Fidel’s research has greatly impacted the fields of medical mycology and infectious disease. Pioneering studies using novel mouse models and human clinical samples have defined unique paradigm-changing aspects of host-pathogen interactions in vaginal and oral candidiasis, including that in HIV disease. Current work focuses on the oral microbiome in HIV disease as well as continuing work in mucosal candidiasis.

Interplay Between Oral Immunity in HIV and the Microbiome (Co-Chair)

David Moyes, BSc, MSc, PhD has an ongoing interest in the interactions between humans and the microbes that co-exist with us. In particular, he is interested in how we discriminate between harmless and harmful microbes and how this affects our general health. He is an experienced post-doctoral scientist with a strong background in research and have published regularly in international journals. He manages several research projects concurrently, coordinating with other members of his team as well as other groups both nationally and internationally. As well as research, He teaches and supervises both undergraduates and post-graduates and is involved in the administration of the department.

HIV Testing: What, Where and How? (Chair)

Anthony Santella, DrPH, MPH, MCHES is an Associate Professor of Public Health and LGBTQ+ Studies at Hofstra University in Long Island, New York. Long Island has the highest number of AIDS cases of any suburban area in the country and more cases than 26 states.

Dr. Santella also serves as Chair of the Long Island Ryan White HIV Planning Council, Governing Councilor of the HIV/AIDS Section of the American Public Health Association (APHA), Chair of the Committee on Health Equity of APHA, Associate Editor for Frontiers in Public Health, and Academic Editor for PLOS One. He also serves on the Board of Directors of The HIV League, a nonprofit organization which provides scholarships to people living with HIV pursuing a university degree.

Dr. Santella is a public health scientist and health services researcher specializing in HIV and STI prevention and sexual health. His research agenda focuses on the integration of primary and secondary prevention in clinical settings. Specifically, his work explores the role of dental professionals (dentists and dental hygienists) in conducting rapid HIV testing in the dental setting. Using qualitative, quantitative, and mixed-methods research he has led, co-led, and advised on projects conducted in the United States, United Kingdom, China, India, Vietnam, and Australia alongside in-country dental clinical and public health scholars. This research has been published in journals such as the Australian Dental Journal, British Dental Journal, Journal of Dental Hygiene, International Journal of Dental Hygiene, and Oral Health and Preventive Dentistry.

He has also received grants from the foundation, university, and government sectors and has presented his work at local, national and international conferences such as the American Public Health Association Annual Meeting, International AIDS Conference, and the International Association of Dental Research Annual Meeting.

Dr. Santella earned a Bachelor of Science in Biomedical Sciences from the University of Connecticut (Storrs, Connecticut, US), a Master of Public Health in Health Policy and Management from Emory University (Atlanta, Georgia, US), a Doctor of Public Health in Health Systems Management from Tulane University (New Orleans, Louisiana, US), and an Advanced Certificate in Health Professions Pedagogy and Leadership from Hofstra University (Long Island, New York, US). He is also a Master Certified Health Education Specialist by the National Commission of Health Education Credentialing.

HPV and Oral Cancer in HIV-Infected Individuals on Long-Term ART: Do the Risks Exist ? (Chair)

Prof. Newell W. Johnson, CMG, FMedSci, FRCPath, FFOPRCPA, FDSRCS, FRACDS, MDSc, Ph.D, FHEA, FOMAA, FICD is currently Professor Emeritus at King's College London and at Griffith University, Queensland, Australia where has served as head of department and Foundation Dean of the dental school. He holds honorary appointments in numerous other universities across the globe. He has been researching and teaching oral/head and neck cancer for over half a century in all continents covering epidemiology, risk factors, diagnostics and treatment outcomes. Active work on HIV/AIDS dates from the early 1990s, in UK, Africa and especially in India. He practices clinical oral medicine and histopathology. Honours include Companion of St Michael and St George from HM Queen Elizabeth, Fellow of the Academy of Medical Sciences (UK) and Distinguished Scientist Award from the International Association of Dental Research. He has published over 400 refereed papers and numerous books and book chapters covering head and neck oncology, HIV disease, diagnostic histopathology, clinical oral medicine, periodontology, cariology and dental education. Notable here is the second edition of his major text Oral and Oropharyngeal Cancer with Jatin Shah, published November 2018 https://www.crcpress.com/Oral-and-Oropharyngeal-Cancer/Shah-MD-FACS-Johnson-CMG-FMedSci-MDSc/p/book/9781498700085

He currently leads a team based in the Menzies Health Institute Queensland researching the above issues, with local collaborators, on projects in Australia, Papua New Guinea, India, Sri Lanka, Bangladesh, Saudi Arabia, Yemen, Kenya, Nigeria, Sudan, South Africa, and Colombia.

He has extensive experience as a supervisor of Higher Degree by Research students, having seen to completion over 20 PhD degrees.

He is a registered specialist in Australia in oral pathology, in oral medicine, and in periodontology.

NWJ November 2018

a

HPV and Oral Cancer in HIV-Infected Individuals on Long-Term ART: Do the Risks Exist ? (Co-Chair)

Jennifer Webster-Cyriaque, Ph.D, DDS is currently associated professor at University of North Carolina. In 1992 Undergraduate double major: Biology and Interdisciplinary Social Science, B.A. State University of New York at Buffalo Dental School (DDS) State University of New York. In 1998 reach Doctor of Philosophy (Ph.D) University of North Carolina Hill in Microbiology and immnunology, Postdoctoral Fellowship, Pathogenesis of Infectious Disease, University of North Carolina at Chapel Hill.

Innate Immunity Mechanisms to Oral Pathogens in Oral Mucosa of HIV Infected Individuals (Chair)

Prof. Julian Naglik graduated with a BSc from the University of East London in 1992 and obtained his Ph.D. from King’s College London in 2001, studying the expression of the secreted aspartyl proteinases in Candida albicans infections. He was appointed Lecturer in 2006, Reader in 2013 and Professor in 2016. Previously, he undertook roles as a visiting research scientist at the Robert Koch Institute (Berlin, Germany) as well as the University of California San Francisco (USA). Julian is currently Professor of Fungal Pathogenesis and Immunology in the Centre for Host-Microbiome Interactions, Faculty of Dental, Oral and Craniofacial Sciences at King’s College London. His current research projects relate to the molecular analysis of host-pathogen interactions at mucosal surfaces, with specific focus on epithelial mechanisms activated by the human fungal pathogen C. albicans. His laboratory described the danger response signalling pathways activated by the invasive hyphal form of C. albicans, which recently was found to be due to the secretion of candidalysin. Candidalysin is the first cytolytic peptide toxin identified in any human fungal pathogen and has been recognised as a seminal advance in the microbiology field. His research is supported by grants from the Medical Research Council (MRC), Biotechnology & Biological Sciences Research Council (BBSRC), National Institutes of Health (NIH) and the Wellcome Trust. Professor Naglik’s research has received awards from King's College London, the German Mycological Society, Heinz Maurer-Prize award, and the German Society for Hygiene and Microbiology. He is also an Honorary Member of the British Society of Medical Mycology.

Innate Immunity Mechanisms to Oral Pathogens in Oral Mucosa of HIV Infected Individuals (Co-Chair)

How Does HIV Infection Affect the Production of Cytokines and Other Innate Antimicrobial Factors?

Dr. Weinberg is a tenured professor in the School of Dental Medicine, chairs its Department of Biological Sciences, and is the School's Associate Dean for Research. He is secondarily appointed in the Department of Pathology and in the Proteomics and Bioinformatics Core in the School of Medicine. He teaches oral microbiology and immunology to dental students and residents. Dr. Weinberg mentors junior faculty and assists them in their research.

Dr. Weinberg's research focuses on innate immune responses of mucosal epithelium to bacteria, fungi, and viruses. Throughout his research career, Dr. Weinberg has combined his clinical background with cutting-edge molecular and cellular biological approaches to research oral diseases.

Innovations for Prevention and Care of Oral Candidiasis in HIV: Are They Available ? (Chair)

Dr. Lauren L. Patton is Professor and Chair of the Department of Dental Ecology at the University of North Carolina at Chapel Hill (UNC) School of Dentistry and Director of the General Practice Residency (GPR) program. She is a Fellow of the American Association of Hospital Dentistry and Diplomate of the American Board of Special Care Dentistry. Current President-elect of the American Academy of Oral Medicine (AAOM), she is a Diplomate and past President of the American Board of Oral Medicine. She earned her DDS at the University of North Carolina, attended the 2-year GPR at UNC, followed by a 2-year Clinical Dental Staff Fellowship with Oral Medicine/Research training at the National Institute of Dental and Craniofacial Research (NIDCR) in Bethesda, MD. During her 28 years on UNC faculty, she has conducted industry and federal government–funded clinical and health services research; participated in teaching at dental hygiene, dental, and post-doctoral levels; published over 140 papers, monographs and book chapters; and lectured internationally on oral manifestations and management of patients with medical complexities, such as HIV/AIDS and oral cancer. In 2013, she received the AAOM’s Samuel Charles Miller Award for Significant Contributions to the Science, Literature, and Patient Care in the Field of Oral Medicine. She serves as a member of the American Dental Association (ADA) Council on Scientific Affairs and is editor of The ADA Practical Guide to Patients with Medical Conditions. She also serves as the Oral Medicine Section Editor of Oral Surg Oral Med Oral Pathol Oral Radiol. She is the UNC site Principal Investigator of the NIDCR-funded Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients (OraRad).

Innovations for Prevention and Care of Oral Candidiasis in HIV: Are They Available ? (Co-Chair)

Dr. Velia Ramirez-Amador is Full-Time Researcher-Professor at the Universidad Autonoma Metropolitana-Xochimilco (UAM-X), Mexico City and Founder and Ex-Director of Studies of the Master Course in Oral Pathology and Oral Medicine at the UAM-X, Mexico City. Member of the National System of Research (National Council in Science and Technology), MEXICO.

Dental Surgeon at the Universidad Nacional Autonoma de México. Master in Science (MSc) in Oral Pathology at the Institute of Dental Surgery, Eastman Dental Hospital, University of London, England. Doctorate (PhD) in Oral Pathology, University of Sheffield, England. Post-doctoral Visiting Associate Professor at the Division of Oral Medicine, Pathology and Radiology. Universidad de California, San Francisco CA, USA.

70 scientific articles, 12 chapters in scientific books and more than 300 presentations in specialized Congresses.

Research interests: Oral manifestations on HIV/AIDS, since 1990 and oral cancer, since 1973.

e-mail: veliaram1@gmail.com

What are the Recent Advances (Since 2015) Regarding Plant-Based and Alternative Medicines in Management of Oral Candidiasis? Is There A Role for Photodynamic Therapy in Management of Oral Candidiasis in HIV-Infected Patients?

Professor Wipawee Nittayananta is a Professor of Oral Medicine, Thammasat University, Pathum Thani, Thailand. She graduated from the Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand in 1989. She was a scholar of the German Academic Exchange Service (Deutscher Akademischer Austausch Dienst; DAAD) to study at the Freie Universität Berlin, Germany, and obtained a degree of Dr. med. dent. in 1994. In 2002, she received a scholarship from the US Fogarty International Center/National Institute of Health to study at the University of Washington, Seattle, USA. She was in a combined program of Oral Medicine and Oral Biology, and obtained her master degree in Oral Medicine in 2005 and a PhD degree in Oral Biology in 2006. Prof. Nittayananta currently serves in Editorial Board of various international journals including Oral Diseases, Journal of Investigative and Clinical Dentistry, and World Journal of Stomatology. Prof. Nittayananta has also been invited to join the World Health Organization (WHO) Taskforce Group on Oral Health in HIV/AIDS since 2005. Her fields of interest in research involve oral mucosal lesions, innovation for oral health, and mucosal innate immunity. She has been a reviewer of various international journals, including Oral Diseases, Journal of Oral Pathology and Oral Medicine, and Archives of Oral Biology, and edited different books such as “Oral Manifestations of HIV Infection”, and “Common Oral Lesions and Orofacial Pain”. Prof. Nittayananta received The 2013 Best Reviewer Award from Oral Diseases.

How does HIV Infection Affect Epithelial and Immune Cell Signalling ?

Sharof M. Tugizov, DVM, Ph.D, DSc has research focus is investigation of the interactions of human viruses, including human cytomegalovirus (HCMV), Epstein–Barr virus (EBV), Herpes simplex virus (HSV), human immunodeficiency virus (HIV), and human papillomavirus (HPV), with monostratified and multistratified oral epithelia. He has made significant contributions to current knowledge about entry, transcytosis, intracellular transport, egress, and cell-to-cell transmission of these viruses in oral epithelial cells by establishing and using polarized epithelial cells, as well as ex vivo oral mucosal tissue explants.

What are the Health Service Implications of Intersectional Stigma Faced by Sexual and Gender Minorities?

Dr. Venkatesan Chakrapani, MD, PhD. is Wellcome/DBT India Alliance Senior Fellow, School of Public Health, PGIMER, Chandigarh; and Chairperson of Centre for Sexuality and Health Research and Policy (C-SHaRP), a not-for-profit research agency in Chennai. He has more than 15 years of experience in conducting applied and policy-oriented health research among marginalised communities such as men who have sex with men, transgender people and people living with HIV. His studies have provided evidence base on: stigma/discrimination and structural violence; barriers to HIV prevention/treatment services and gender transition; social/sexual networks and sexual risk; impact of sexual minority stigma on mental health and HIV risk, syndemics and HIV risk; and acceptability of new HIV prevention technologies. He has received several fellowships including NIH Fogarty fellowship at Yale University, USA; and the Fund for Leadership Development fellowship of the MacArthur Foundation. He has authored/co-authored 43 peer-reviewed journal articles, more than 50 technical/policy reports and five book chapters.

What Community Based Interventions are Working and How do We Scale Up ? What are the Challenges ?

Vaishali S Mahendra, B.Sc., M.Sc. has over twenty years of experience in the health and social development sector in India and South Asia. Focus of her work has been on generating evidence and creating knowledge through research, implementation, evaluation and documentation of programmes. She has a Masters degree in Human Development and Childhood Studies from Delhi University. During her work with CARE and Population Council in India, Vaishali helmed many path-breaking research studies and projects on Sexual and Reproductive Health, HIV, Gender Equity and Maternal & Child Health. Using a rights based approach, she worked explicitly on addressing stigma and discrimination, human rights violations and structural impediments against people living with HIV/AIDS, women, adolescents and other key affected populations. Her pioneering work on understanding and reducing HIV stigma and making health facilities safer for health practitioners has been adapted and scaled up in several settings, nationally and internationally. A strong belief in community involvement and people’s participation has guided her work and enriched not only her career, but her personal life as well. Over the past ten years, Vaishali has worked as an independent consultant and has had the opportunity to work with several stakeholders on a multitude of health and development issues. Her commitment to giving back has also seen her volunteering for various important social causes, nationally and internationally. Currently, she is volunteering with a Delhi based agency that provides crisis intervention services on mental health issues. She is also gearing up to enrol for a Doctoral degree, a long-cherished goal.

How is the Mucosal Distribution and Function of Immune Cells Altered in HIV Infection ?

Pushpa Pandiyan, Ph.D is assistant Professor, Biological Sciences, School of Dental Medicine. She has finished Postdoctoral Fellowship, National Academy of Sciences in 2009. She is studying the mechanisms by which unwanted immune responses are regulated and focusing on how regulatory T cells (Tregs) and cytokine networks control inflammatory cells in different disease settings. Her Specialties is mucosal Immunity/Autoimmunity- Role of cytokine feedback regulation and TLR signaling in Treg/Th17 homeostasis, differentiation and plasticity

How does HIV Infection Lead to Susceptibility to TB Infections ?

Dr. Annapurna Vyakarnam is Visiting Professor Centre for Infectious Disease Research Indian Institute of Science, CV Raman Avenue, Bangalore, India and Adjunct Professor at St John’s Research Institute St John’s Hospital Medical School, Bangalore & National Institute for TB Research, Chennai, India. Her laboratory probes host pathogen interactions and adaptive immunity pertinent to human immunodeficiency virus (HIV) and HIV-tuberculosis (TB) coinfection. Specifically she focus on understanding CD4 T cell function, which is a key orchestrator of immunity to both HIV and Mycobacterium tuberculosis (Mtb) and plays a central role in disease process. Tuberculosis (TB) is the most important opportunistic infectious disease in HIV infected subjects, especially in TB endemic areas, like India and South Africa. TB in these patients may result from reactivation of latent infection or from new infection. While most opportunistic infections tend to present late in the course of HIV infection when CD4 T cell counts have declined, the risk of TB is substantially increased at all stages of HIV infection including those with preserved CD4 T cell counts. Consequently, HIV infection has dramatically increased TB incidence globally. Given the global increase in multidrug resistant (MDR) TB, there is strong consensus in the scientific community and funding bodies of the need to improve our understanding of the mechanisms that drive selective early presentation of TB in HIV+ve patients and the associated need to develop effective therapeutic strategies in the treatment of HIV-TB coinfection.

What are the Roles of Confounding Factors and Comorbidities of High Risk and Low Risk HPVs Associated Oral Diseases in People on Long-Term ART ?

Dr. Gabriela Anaya Saavedra, Ph.D is a versatile writer and researcher that published extensively in specialized field. She is working in Universidad Autónoma Metropolitana-Xochimilco, Mexico. Her Research interest in Oral Pathology, Tuberculosis, Oral Cancer, Oral Surgery, Cancer Biology, HIV Infection, Epigenetics Cancer Immunology, Oral and Maxillofacial Surgery, Viral Load, Cancer Diagnostics, Pathology, TB-HIV, Stata Software.

How does Local/Systemic Innate or Adaptive Immune Cells Alter the Oral Microbiome ? How does Immune Compromised Conditions or Vaccination (i.e. HPV Vaccine) Influence the Oral Microbiome ?

Prof. Lakshman Samaranayake was Professor of Oral Microbiomics and Infection and Head of the School of Dentistry, University of Queensland, Australia (2014 – 2016). He was also Professor of Bioclinical Sciences, Kuwait University (2016-2017). Since 2017 he has been Professor and Vice-Dean, College of Dental Medicine, Sharjah University, UAE. He received several major honors and awards - Distinguished Scientist Award of IADR (2010), King James IV Professorship of the Royal College of Surgeons of Edinburgh, UK (2012), the Tam Wah-Ching Endowed Professor in Dental Science of the Hong-Kong University (2010-2013). He has served as member of various editorial boards and university exam boards. Professor Samaranayke has published over 350 original, peer reviewed research and review articles, 31 book chapters and more than 150 abstracts, more than 450 scientific communications, and has been cited in the literature over 19,000 occasions, with an H-index of 73 derived from. Research interests: infections in medically compromised individuals; oral candidiasis; clinical oral microbiology; infection control in dental practice.

What is the Role of ART on Oral Immunity and the Microbiome in Well-Controlled HIV+ Patients with Identified Chronic Inflammation ?

Dr. Hagensee earned his MD and PhD from Baylor College of Medicine in Houston. He completed an internal medicine residency and a fellowship in infectious diseases at University of Washington Affiliated Hospitals in Seattle, Washington. From 1994 to 1996, he was a post-doctoral fellow at the Fred Hutchinson Research Center and an instructor in the division of Infectious diseases at the University of Washington Affiliated Hospital. He joined the faculty of LSU School of Medicine in 1996 as an assistant professor in the section of infectious diseases. Dr. Hagansee’s laboratory is studying the interaction of EBV and HPV in the development of cervical dysplasia in HIV, looking for ways to improve existing HPV serological assays, and examining the role of EBV in HPV-related cervical dysplasia in HIV-negative women. He is board certified in both internal medicine and infectious diseases. Research Interests : The Hagensee laboratory studies the role of human papillomavirus (HPV) in human malignancies. Studies are focused on the increase in HPV-related cervical cancer in HIV+ women and the increase in oral cancer in HIV+ men and women. A new area of focus is the role of HPV in anal cancer from basic biology to clinical trials and similar increases in anal cancer rates in HIV+ individuals. This increase may be due, in part, to an interaction with another DNA virus, Epstein Barr Virus (EBV) which also causes human cancers. Current projects include detection of HPV and EBV in clinical specimens, determination of the systemic and local immune response against each virus, in-vitro modeling techniques and development of xenograft mouse models. Results from these studies will aid in improved diagnostics and preventive measures for these cancers. Additional projects include development of self-testing methods to detect HPV DNA to improve cervical cancer screening and studies into improvement of HPV vaccine implementation.

HIV Testing: What, Where and How ? (Co-Chair)

What are the Current Concepts/Advances in HIV Self-Testing Diagnostics and How Can We Integrate and Support Self-Testing for HIV in Healthcare Settings?

Mohammed is the Technical Head: HIV Self-Testing at the Wits Reproductive Health and HIV Research Institute in Johannesburg, South Africa. He is an experienced researcher with a laboratory medicine background who has headed several multi-centre randomised controlled clinical trials at the Institute focussing on Antiretroviral Drug Dosage Optimisation and HIV Self-Testing Usability. Mohammed took over the HIVST portfolio at Wits RHI in 2014 and has spear-headed the programme which is primarily assessing a variety of prospective test kits in the hands of untrained users. He is the Technical Lead for the STAR Initiative at Wits RHI. He chairs the South African HIV Clinicians Societies HIVST Technical Working Group and is leading the engagement with various facets of the National Department of Health. He was the lead author for the Recommended HIV Self-Testing Guidelines published by the SA HIV Clinicians Society. Mohammed completed his MBA in 2016 with his dissertation focussing on the market entry barriers for HIVST in South Africa. His current research focuses on the performance evaluation and optimization of prospective HIV Self-test products in the South African market.

How to We Build Lay Provider Capacity to Deliver HIV Testing in the Community ?

Huu Van Ngo, MD, MPH graduated from Ha Noi Medical University in Vietnam as a general medical doctor and obtained a Master of Public health degree from the University of Washington in the United States. Initially, he worked for over ten years as a clinical doctor and a lecturer at Hai Phong Medical University. Over the last 15 years, Huu has worked in many public health areas, such as reproductive health and HIV/AIDS. Since 2015, Huu has worked as Technical Director at PATH, a US-based International Non-government Organization in Vietnam. In this position, he led his team to pilot and then roll out community-based HIV testing, including HIV lay provider testing, HIV self-testing and index clients testing with great success in Vietnam. He also provided technical assistance to the Vietnam Administration for HIV/AIDS Control, Ministry of Health, to develop National Guidelines on HIV community-based testing and the accompanying training materials and tools. His work also extends to other HIV related areas such as pre-exposure prophylaxis (PrEP) and post-exposure propylaxis (PEP), for key populations in Vietnam.

How Does HIV Stigma Manifest in the Healthcare Setting?

Dr. Evy Yunihastuti graduated as Medical Doctor from Universitas Indonesia, Jakarta in 1997, when she started working with HIV patients. She shown a great interest in HIV and hepatitis co-infected patients and had published several articles regarding this co-infection in Indonesia. Her PhD project was about hepatitis C immune reconstitution syndrome among HIV-HCV co-infected patients starting HAART. Her current position is lecturer in Faculty of Medicine Universitas Indonesia, general secretary of Indonesian Association of Physicians in AIDS Care, and medical coordinator of HIV Integrated Clinic (previously known as Working Group on AIDS/Pokdisus AIDS) Cipto Mangunkusumo hospital, the largest HIV center in Indonesia.

How do T Cells Effect HIV (Oral) Pathogenesis and Cancer?

Ge Jin, Ph.D. is an Associate Professor in the Department of Biological Sciences, Case Western Reserve University School of Dental Medicine, USA. Dr. Jin’sresearch interest focuses on the mechanism underlying cancer cell-derived cytokines and/or metabolites and immune response and the role of HIV-infection in the development and progression of non-AIDS-defining cancers. His specialties are Physiology and Biophysics, Cell and Developmental Biology.

What have We Learned from Expanding HIV Testing Beyond the Specialist Setting?

Dr. Hendry Luis received his medical degree from the University of Gadjah Mada in 2002-2007, he was as a GP Trained in HIV & STI, Volunteer at Bali Peduli since 2012, Joined Bali Peduli in 2016 & now serves as Executive Director of Bali Peduli Foundation.

How do People Living with HIV Contribute to Research, Policy and Practice?

Adit has a lot of experience in developing projects in field of HIV and AIDS and drugs. He has successfully prepared Rumah Cemara in the international involvement through participation in global networks such as the International HIV/AIDS Alliance, IDPC, and the Streetfootballworld. Some of his successful proposals have brought programs funded by BUZA, European Commission, FIFA Football for Hope, General Motors – on Manchester United-ChevroletFC, Sony Mobile, Cityzens Giving by Manchester City Foundation. He has successfully initiated the development of an innovative approach to HIV and AIDS and drugs interventions through sports for development. This has been recognized by the award winning program by Ashoka-Changemakers in 2010, and the 2013 Beyond Sports Award shortlist. On the other path of his career, Adit is experienced in people management and delivering client-oriented programs, managing 50+ staff, catering up to 1,200 customers and on average 10 in-house clients every year.

Clinical Management of Oral Manifestations of HIV and Other Systemic Disease

Prof. Stephen J. Challacombe, BDS, Ph.D, FDSRCSEd, FRCPAth, FmedSci, FDSRCS. is a renowned researcher and clinical specialist in oral medicine. He is the Martin Rushton Professor of Oral Medicine in University of London & King’s College London. He is past President of the International Association for Dental Research (IADR) and current president of the Hunterian Society. He has had a long professional interest in the oral manifestations of HIV and on mucosal immunity in HIV which has led to over 25 research papers. He was part of the consensus meeting on the classification of the oral lesions in HIV in 1991 and 1993. Since 1996, He was the Co-chairman of International workshops on the oral manifestations of HIV infection in the UK, South Africa, Thailand, China, and India. From 2000-2017 he was Chairman of the International steering committee on Oral Health & Disease in HIV infection. He has been an author or co-author of over 240 peer-reviewed research papers and 160 other publications on Mucosal immunity; Immunological, dermatological and microbiological aspects of oral diseases; Oral medicine; Candida infections; Immunological aspects of Dental Caries, Oral manifestations of HIV infection, Oral Tolerance. Editor or co-editor of 9 books on Food Allergy, Food Allergy & Intolerance, Practical and Theoretical aspects of ELISA, Oral Aids Research, and Immunology of oral diseases. Early in his academic career he was an Assistant Professor & Senior Research Fellow in the Department of Immunology, Mayo Clinic, USA (1978-1979), and his career includes serving as Dean for International Affairs, KCL health Schools (2007-2012). He served as President of British Society for Oral Medicine (1995-1997), President of European Association of Oral Medicine (2008-2010), and from 2007- 2013, he was Chairman of the Expert Specialist Advisory Group for OHARA (oral section of Aids clinical trials group). In addition to all his tremendous activities related to oral health and diseases in HIV/AIDS, he also has extensive experience in administration which includes running the University departments, organising conferences, managing grants, budgets and research, teaching and clinical activities. He has received a number of awards for his research. Recently, he received a Samuel Charles Miller award from the American Academy of Oral Medicine.

Principles of Surgical Dentistry for HIV Patients

Prof. Paul Coulthard BDS, MFGDP(UK), MDS, FDSRCS, FDS(OS)RCS, PhD is Dean for Dentistry and Director at ‘Barts and The London School of Medicine and Dentistry’, Queen Mary University of London, and Professor of Oral and Maxillofacial Surgery. He is Consultant in Oral Surgery at ‘Barts Health NHS Trust’ that includes St Bartholomew’s Hospital and The Royal London Hospital. He was previously Head of the Manchester Medical School and Research Institutes of Cancer Sciences, Cardiovascular Sciences, Developmental Biology & Medicine, Diabetes, Endocrinology & Gastroenterology. Prior to this he was Manchester Dental School Dean for five years. Alongside surgical training, Professor Coulthard undertook research training leading to the award of an MDS in Oral and Maxillofacial Surgery and a PhD in Neuroscience. He has published over 180 scientific papers. Professor Coulthard has chaired several recent committees for ‘NHS England’ that have published reports changing the delivery of clinical care in England. He is President-Elect of the ‘British Association of Oral Surgeons’ becoming President in September 2019. Professor Coulthard is actively involved in undergraduate and postgraduate teaching and learning. He is passionate about Evidence-Based Practice and teaching this concept to students. He is principal author of a textbook Oral and Maxillofacial Surgery, Radiology, Pathology and Oral Medicine (Master Dentistry Volume 1) and has also authored chapters for six other textbooks.

Dental Treatment Considerations for HIV Patients: to Do and not to Do.

Dr. Lauren L. Patton is Professor and Chair of the Department of Dental Ecology at the University of North Carolina at Chapel Hill (UNC) School of Dentistry and Director of the General Practice Residency (GPR) program. She is a Fellow of the American Association of Hospital Dentistry and Diplomate of the American Board of Special Care Dentistry. Current President-elect of the American Academy of Oral Medicine (AAOM), she is a Diplomate and past President of the American Board of Oral Medicine. She earned her DDS at the University of North Carolina, attended the 2-year GPR at UNC, followed by a 2-year Clinical Dental Staff Fellowship with Oral Medicine/Research training at the National Institute of Dental and Craniofacial Research (NIDCR) in Bethesda, MD. During her 28 years on UNC faculty, she has conducted industry and federal government–funded clinical and health services research; participated in teaching at dental hygiene, dental, and post-doctoral levels; published over 140 papers, monographs and book chapters; and lectured internationally on oral manifestations and management of patients with medical complexities, such as HIV/AIDS and oral cancer. In 2013, she received the AAOM’s Samuel Charles Miller Award for Significant Contributions to the Science, Literature, and Patient Care in the Field of Oral Medicine. She serves as a member of the American Dental Association (ADA) Council on Scientific Affairs and is editor of The ADA Practical Guide to Patients with Medical Conditions. She also serves as the Oral Medicine Section Editor of Oral Surg Oral Med Oral Pathol Oral Radiol. She is the UNC site Principal Investigator of the NIDCR-funded Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients (OraRad).

Preventing Infection Transmission in Dental Surgeries – Knowledge and Behavior

Professor Wipawee Nittayananta is a Professor of Oral Medicine, Thammasat University, Pathum Thani, Thailand. She graduated from the Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand in 1989. She was a scholar of the German Academic Exchange Service (Deutscher Akademischer Austausch Dienst; DAAD) to study at the Freie Universität Berlin, Germany, and obtained a degree of Dr. med. dent. in 1994. In 2002, she received a scholarship from the US Fogarty International Center/National Institute of Health to study at the University of Washington, Seattle, USA. She was in a combined program of Oral Medicine and Oral Biology, and obtained her master degree in Oral Medicine in 2005 and a PhD degree in Oral Biology in 2006. Prof. Nittayananta currently serves in Editorial Board of various international journals including Oral Diseases, Journal of Investigative and Clinical Dentistry, and World Journal of Stomatology. Prof. Nittayananta has also been invited to join the World Health Organization (WHO) Taskforce Group on Oral Health in HIV/AIDS since 2005. Her fields of interest in research involve oral mucosal lesions, innovation for oral health, and mucosal innate immunity. She has been a reviewer of various international journals, including Oral Diseases, Journal of Oral Pathology and Oral Medicine, and Archives of Oral Biology, and edited different books such as “Oral Manifestations of HIV Infection”, and “Common Oral Lesions and Orofacial Pain”. Prof. Nittayananta received The 2013 Best Reviewer Award from Oral Diseases.

Getting Published: Sharing Knowledge to Stop HIV/AIDS

How to Build Trust with HIV Patients

Dr. Amitha Ranauta BDS, LLM is a Dentist from Queen Mary & Westfield & Barts And The London School of Medicine and Dentistry in 1996. Whilst working in General Dental Practice Amitha gained her LLM in Legal Aspects of Medical Practice from Cardiff University. Currently Amitha is working as a clinical lecturer at Queen Mary & Westfield & Barts and The London School of Medicine and Dentistry. She is involved in teaching hygiene & therapy students and undergraduate dental students. She is doing a PhD thesis exploring the topic of development professionalism in udenrgraduate dental students.